Funding Round
MindMaze raises $130M Series D to expand neurorehabilitation VR globally
Financial Times3/13/2026·03/13/26🌐 Europe
Summary
Swiss unicorn MindMaze secured $130M Series D led by the Hinduja Group, with Johnson & Johnson Innovation and Endeavour Vision. MindMotion VR neurorehabilitation is now deployed in 130+ hospitals. Funds support US commercial expansion, a new TBI indication launch, and development of MindMaze Home for outpatient VR rehabilitation.
Why it matters
MindMaze entering the US home rehabilitation market is a major strategic move — the US stroke rehab market alone exceeds $10B annually. J&J Innovation's continued participation suggests interest in a future acquisition or deeper commercial partnership.
#BCI#Industry#Neurostimulation#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in